The in vitro respiratory toxicity of cristobalite-bearing volcanic ash

Environmental Research

Volumn 145, Issue , 2016, Pages 74-84

  Damby, David E ^a,b,c   Murphy, Fiona A ^d   Horwell, Claire J ^a   Raftis, Jennifer ^b   Donaldson, Kenneth ^b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Cristobalite; Crystalline silica; Toxicity; Volcanic ash

Indexed keywords

GLUTATHIONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; SILICON DIOXIDE; PARTICULATE MATTER;

A549 CELL LINE; APOPTOSIS; ARTICLE; CELL STRESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; LUNG TOXICITY; MACROPHAGE; PRIORITY JOURNAL; RESPIRATORY TOXICITY; VOLCANIC ASH; ANALYSIS; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; OXIDATIVE STRESS; PARTICLE SIZE; PARTICULATE MATTER; RESPIRATORY SYSTEM; SURFACE PROPERTY; TOXICITY; TUMOR CELL LINE; VOLCANO;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; OXIDATIVE STRESS; PARTICLE SIZE; PARTICULATE MATTER; RESPIRATORY SYSTEM; SILICON DIOXIDE; SURFACE PROPERTIES; VOLCANIC ERUPTIONS;

EID: 84947983432     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2015.11.020     Document Type: Article

References (53)

1. Agopyan N., Head J., Yu S., Simon S.A. Trpv1 receptors mediate particulate matter-induced apoptosis. Am. J. Physiol.: Lung Cell. Mol. Physiol. 2004, 286:563-572.
2. Akematsu T., Dodson R.F., Williams M.G., Hurst G.A. The short-term effects of volcanic ash on the small airways of the respiratory system. Environ. Res. 1982, 29:358-370.
3. Balmes J. Silica exposure and tuberculosis: an old problem with some new twists. J. Occup. Med. 1990, 32:114-115.
4. Baxter P.J., Bonadonna C., Dupree R., Hards V.L., Kohn S.C., Murphy M.D., et al. Cristobalite in volcanic ash of the soufriere hills volcano, montserrat, british west indies. Science 1999, 283:1142-1145.
5. Baxter P.J., Searl A., Cowie H.A., Jarvis D., Horwell C.J. Evaluating the Respiratory Health Risks of Volcanic Ash at the Eruption of the Soufrière Hills Volcano, Montserrat, 1995-2010 2014, Geological Society of London, United Kingdom, Memoir.
6. Bérubé K.A., Jones T.P., Housley D.G., Richards R.J. The respiratory toxicity of airborne volcanic ash from the soufriere hills volcano, montserrat. Miner. Mag. 2004, 68:47-60.
7. Biswas S., Rahman I. Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Mol. Asp. Med. 2009, 30:60-76.
8. Bonner J.C., Rice A.B., Lindroos P.M., O'Brien P.O., Dreher K.L., Rosas I., et al. Induction of the lung myofibroblast pdgf receptor system by urban ambient particles from mexico city. Am. J. Respir. Cell Mol. Biol. 1998, 19:672-680.
9. Brown D.M., Beswick P.H., Bell K.S., Donaldson K. Depletion of gluathione and ascorbate in lung lining fluid by respirable fibres. Ann. Occup. Hyg. 2000, 44:101-108.
10. Brown J.S., Gordon T., Price O., Asgharian B. Thoracic and respirable particle definitions for human health risk assessment. Part. Fibre Toxicol. 2013, 10:12.
11. Castranova V., Bowman L., Shreve J.M., Jones G.S., Miles P.R. Volcanic ash: toxicity to isolated lung cells. J. Toxicol. Environ. Health 1982, 9:317-325.
12. Cullen R.T., Jones A.D., Miller B.G., Donaldson K., Davis J.M.G., Wilson M., et al. Toxicity of Volcanic Ash From Montserrat 2002, Institute of Occupational Medicine, Edinburgh, TM/02/01.
13. Damby D.E. From Dome to Disease: The Respiratory Toxicity of Volcanic Cristobalite (e-theses) 2012, 1-258. Durham University, United Kingdom.
14. Damby D.E., Horwell C.J., Baxter P.J., Delmelle P., Donaldson K., Dunster C., et al. The respiratory health hazard of tephra from the 2010 centennial eruption of merapi with implications for occupational mining of deposits. J. Volcanol. Geotherm. Res. 2013, 261:376-387.
15. Damby D.E., Llewellin E.W., Horwell C.J., Williamson B.J., Najorka J., Cressey G., et al. The alpha-beta transition in volcanic cristobalite. J. Appl. Crystallogr. 2014, 47:1205-1215.
16. Donaldson K., Borm P.J.A. The quartz hazard: a variable entity. Ann. Occup. Hyg. 1998, 42:287-294.
17. Driscoll K.E., Hassenbein D.G., Carter J., Poynter J., Asquith T.N., Grant R.A., et al. Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. Am. J. Respir. Cell Mol. Biol. 1993, 8:311-318.
18. Duffin R., Gilmour P.S., Schins R.P.F., Clouter A., Guy K., Brown D.M., et al. Aluminium lactate treatment of dq12 quartz inhibits its ability to cause inflammation, chemokine expression, and nulcear factor-κb activation. Toxicol. Appl. Pharmacol. 2001, 176:10-17.
19. Fruchter J.S., Robertson D.E., Evans J.C., Olsen K.B., Lepel E.A., Laul J.C., et al. Mount st. Helens ash from the 18 may 1980 eruption: chemical, physical, mineralogical, and biological properties. Science 1980, 209:1116-1125.
20. Geiser T., Jarreau P.H., Atabai K., Matthay M.A. Interleukin-1 beta augments in vitro alveolar epithelial repair. Am. J. Physiol.: Lung Cell. Mol. Physiol. 2000, 279:L1184-L1190.
21. Green F.H.Y., Vallyathan V., Mentnech M.S., Tucker J.H., Merchant J.A., Kiessling P., et al. Is volcanic ash a pneumoconiosis risk?. Nature 1981, 293:216-217.
22. Green F.H.Y., Bowman V., Castranova V., Dollberg D.D., Elliot J.A., Fedan J.S., et al. Health implications of the mount st. Helens' eruption: laboratory investigations. Ann. Occup. Hyg. 1982, 26:921-933.
23. Hetland R.B., Schwarzel P.E., Johansen B.V., Myran T., Uthus N., Refsnes M. Silica-induced cytokine release from a549 cells: importance of surface area versus size. Hum. Exp. Toxicol. 2001, 20:46-55.
24. Hillman S.E., Horwell C.J., Densmore A.L., Damby D.E., Fubini B., Ishimine Y., et al. Sakurajima volcano: a physico-chemical study of the health consequences of long-term exposure to volcanic ash. Bull. Volcanol. 2012, 74:913-930.
25. Horwell C.J., Sparks R.S.J., Brewer T.S., Llewellin E.W., Williamson B.J. The characterisation of respirable volcanic ash from the soufriere hills volcano, montserrat, with implications for health hazard. Bull. Volcanol. 2003, 65:346-362.
26. Horwell C.J., Baxter P.J. The respiratory health hazards of volcanic ash: a review for volcanic risk mitigation. Bull. Volcanol. 2006, 69:1-24.
27. Horwell C.J., Fenoglio I., Fubini B. Iron-induced hydroxyl radical generation from basaltic volcanic ash. Earth Planet. Sci. Lett. 2007, 261:662-669.
28. Horwell C.J., Le Blond J.S., Michnowicz S.A.K., Cressey G. Cristobalite in a rhyolitic lava dome: evolution of an ash hazard. Bull. Volcanol. 2010, 72:249-253.
29. Horwell C.J., Williamson B.J., Donaldson K., Le Blond J.S., Damby D.E., Bowen L. The structure of volcanic cristobalite in relation to its toxicity; relevance for the variable crystalline silica hazard. Part. Fibre Toxicol. 2012, 9:44.
30. Horwell C.J., Baxter P.J., Hillman S.E., Calkins J.A., Damby D.E., Delmelle P., et al. Physicochemical and toxicological profiling of ash from the 2010 and 2011 eruptions of eyjafjallajökull and grímsvötn volcanoes, iceland using a rapid respiratory hazard assessment protocol. Environ. Res. 2013, 127:63-73.
31. Horwell C.J., Williamson B.J., Llewellin E.W., Damby D.E., Le Blond J.S. The nature and formation of cristobalite at the soufrière hills volcano, montserrat: implications for the petrology and stability of silicic lava domes. Bull. Volcanol. 2013, 75:696.
32. Horwell C.J., Hillman S.E., Cole P.D., Loughlin S.C., Llewellin E.W., Damby D.E., et al. Controls on Variations in Cristobalite Abundance in Ash Generated by the Soufrière Hills Volcano, Montserrat in the Period 1997 to 2010 2014, Geological Society, London, Memoirs.
33. Housley D.G., Bérubé K.A., Jones T.P., Anderson S., Pooley F.D., Richards R.J. Pulmonary epithelial response in the rat lung to instilled montserrat respirable dusts and their major mineral components. Occup. Environ. Med. 2002, 59:466-472.
34. Huang Y.-C.T., Li Z., Harder S.D., Soukup J.M. Apoptotic and inflammatory effects induced by different particles in human alveolar macrophages. Inhal. Toxicol. 2004, 16:863-878.
35. Jones T., BéruBé K. The bioreactivity of the sub-10 μm component of volcanic ash: Soufrière hills volcano, montserrat. J. Hazard. Mater. 2011, 194:128-134.
36. Kelly F.J., Blomberg A., Frew A., Holgate S.T., Sandstrom T. Antioxidant kinetics in lung lavage fluid following exposure of humans to nitrogen dioxide. Am. J. Respir. Crit. Care Med. 1996, 157:1027-1033.
37. Le Blond J.S., Cressey G., Horwell C.J., Williamson B.J. A rapid method for quantifying single mineral phases in heterogeneous natural dust using x-ray diffraction. Powder Diffr. 2009, 24:17-23.
38. Le Bouffant L., Daniel H., Martin J.C., Bruyère S. Effect of impurities and associated minerals on quartz toxicity. Ann. Occup. Hyg. 1982, 26:625-634.
39. Martin T.R., Ayars G., Butler J., Altman L.C. The comparative toxicity of volcanic ash and quartz: effects on cells derived from the human lung. Am. Rev. Respir. Dis. 1984, 130:778-782.
40. McLemore T.L., Mauldin J.E., Marshall M.V., Teague R., Ford G., Busbee D.L., et al. Biological effects of mount saint helens volcanic ash on cultured human alveolar macrophages. J. Am. Coll. Toxicol. 1984, 3:25-35.
41. Monick M.M., Baltrusaitis J., Powers L.S., Borcherding J.A., Caraballo J.C., Mudunkotuwa I., et al. Effects of eyjafjallajökull volcanic ash on innate immune system responses and bacterial growth in vitro. Environ. Health Perspect. 2013, 121:691-698.
42. Monteiller C., Tran L., MacNee W., Faux S., Jones A., Miller B., et al. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: The role of surface area. Occup. Environ. Med. 2007, 64:609-615.
43. Mossman B.T., Glenn R.E. Bioreactivity of the crystalline silica polymorphs, quartz and cristobalite, and implications for occupational exposure limits (oels). Crit. Rev. Toxicol. 2013, 1-29.
44. Poland C.A., Miller M.R., Duffin R., Cassee F. The elephant in the room: Reproducibility in toxicology. Part. Fibre Toxicol. 2014, 11:42.
45. Sandberg W.J., Låg M., Holme J.A., Friede B., Gualtieri M., Kruszewski M., et al. Comparison of non-crystalline silica nanoparticles in il-1β release from macrophages. Part. Fibre Toxicol. 2012, 9:32.
46. Sanders C.L., Rhoads K., Mahaffey J.A. Long-term reactivity of lung and mediastinal lymph nodes following intratracheal instillation of sandy loam soil or mount st. Helens volcanic ash. Environ. Res. 1983, 32:188-198.
47. Schins R.P.F., Donaldson K. Nuclear factor kappa-b activation by particles and fibers. Inhal. Toxicol. 2000, 12:317-326.
48. Vallyathan V., Mentnech M.S., Stettler L.E., Dollberg D.D., Green F.H.Y. Mount st helens' volcanic ash: hemolytic activity. Environ. Res. 1983, 30:349-360.
49. Vallyathan V., Robinson V., Reasor M., Stettler L., Bernstein R. Comparative in vitro cytotoxicity of volcanic ashes from mount st. Helens, el chichon, and galunggung. J. Toxicol. Environ. Health 1984, 14:641-654.
50. Wakefield J. An eruption of silicosis. Environ. Health Perspect. 2000, 108:A302.
51. Wehner A.P., Dagle G.E., Clark M.L., Buschbom R.L. Lung changes in rats following inhalation exposure to volcanic ash for two years. Environ. Res. 1986, 40:499-517.
52. Wilson M.R., Stone V., Cullen R.T., Searl A., Maynard R.L., Donaldson K. In vitro toxicology of respirable montserrat volcanic ash. Occup. Environ. Med. 2000, 57:727-733.
53. World Health Organisation, 2011. Tuberculosis in the South-East Asia Region.